Completed PHASE4 INTERVENTIONAL 2-arm NCT01439815

An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo

A Single-Center, Randomized, Double-Masked, Placebo-Controlled Evaluation of the Efficacy of Flonase (Fluticasone Propionate Nasal Spray) Compared to Placebo Nasal Spray in the Allergen BioCube (ABC) Model

Sponsor: ORA, Inc.

Conditions Allergic Conjunctivitis Allergic Rhinitis

Interventions Fluticasone Propionate Nasal Spray Saline Nasal Spray

Updated 10 times since 2017 Last updated: Mar 24, 2021 Started: Sep 30, 2011 Primary completion: Oct 31, 2011 Completion: Oct 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Allergic Conjunctivitis and Allergic Rhinitis, this trial is completed. The trial is conducted by ORA, Inc. and has accumulated 10 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
May 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 5 earlier versions

Apr 2021 — May 2021 [monthly]

Completed PHASE4
Jan 2021 — Apr 2021 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ORA, Inc.

Data source: ORA, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Andover, United States